AorTech International PLC Change of Adviser (8948W)
20 November 2017 - 6:01PM
UK Regulatory
TIDMAOR
RNS Number : 8948W
AorTech International PLC
20 November 2017
20 November 2017
AorTech International plc
("AorTech" or the "Company")
Change of adviser
AorTech International plc (AIM: AOR), the biomaterials and
medical device IP company, announces the appointment of Stockdale
Securities Limited as its Nominated Adviser and Broker with
immediate effect.
For further information contact:
AorTech International plc Tel: +44 (0)7730 718296
Bill Brown, Chairman
Stockdale Securities Limited Tel: +44 20 7601 6100
Tom Griffiths/El-Hanan Lee
About AorTech:
AorTech has developed biostable, implantable polymers, including
Elast-Eon(TM) and ECSil(TM) the world's leading long-term
implantable co-polymers, now manufactured on their behalf by
Biomerics LLC in Utah, USA. With several million implants and seven
years of successful clinical use, AorTech polymers are being
developed and used in cardiology and urological applications,
including pacing leads, cardiac cannulae, stents and neuro
stimulation devices. Devices manufactured from AorTech polymers
have numerous US FDA PMA approvals, 510ks, CE Marks, Australian TGA
and Japanese Ministry of Health approvals.
Elast-Eon(TM) and ECSil(TM)'s biostability is comparable to
silicone while exhibiting excellent mechanical, blood contacting
and flex-fatigue properties. These polymers can be processed using
conventional thermoplastic extrusion and moulding techniques. A
range of materials in a variety of application-specific
formulations for use in medical devices and components are
available.
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPLLFLDLRLDLID
(END) Dow Jones Newswires
November 20, 2017 02:01 ET (07:01 GMT)
Rua Life Sciences (LSE:RUA)
Historical Stock Chart
From Apr 2024 to May 2024
Rua Life Sciences (LSE:RUA)
Historical Stock Chart
From May 2023 to May 2024